TINA: a geometry-aware post-hoc scoring framework for protein-protein interaction.

IF 10.4 1区 医学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Lin-Long Jiang, Yu-Rong Li, Qun Su, Sheng-Tao Cheng, Long-Ji Shen, Ke Zhang, Kai Zhu, Hui Zhang, Chao Shen, Yu Kang, Ting-Jun Hou
{"title":"TINA: a geometry-aware post-hoc scoring framework for protein-protein interaction.","authors":"Lin-Long Jiang, Yu-Rong Li, Qun Su, Sheng-Tao Cheng, Long-Ji Shen, Ke Zhang, Kai Zhu, Hui Zhang, Chao Shen, Yu Kang, Ting-Jun Hou","doi":"10.1038/s41401-026-01937-z","DOIUrl":null,"url":null,"abstract":"<p><p>Accurate identification of the most native-like conformation remains a critical bottleneck in protein complex structure prediction, particularly when multiple globally plausible candidate models are generated by deep learning methods such as AlphaFold3 (AF3). While AF3 provides internal confidence metrics such as ipTM and pLDDT, these signals often lack sufficient sensitivity to distinguish subtle but structurally meaningful differences in local interface geometry. Here, we present TINA, a geometry-aware post-hoc scoring framework designed for fine-grained ranking and selection among high-quality protein complex candidates. TINA constructs atom-level interface graphs and explicitly models two-body, three-body, and four-body geometric interactions through a many-body tensor modeling strategy, enabling a more comprehensive characterization of local contact patterns, angular arrangements, and torsional constraints. The model is initially trained using a joint ranking and regression objective on a large decoy set generated by ZDOCK, with additional task-specific fine-tuning for protein-peptide complexes, and is evaluated exclusively on AF3-generated candidate pools across four independent benchmarks covering general protein-protein, antibody-antigen, protein-peptide, and antibody-peptide complexes. TINA consistently achieves superior or competitive performance in terms of top-1 success rate, enrichment factor, and top-1 DockQ quality. Notably, its benefit is most pronounced in low-confidence and antibody-related scenarios, where AF3 internal ranking signals are less effective in discriminating among candidate conformations. Representative case studies demonstrate that TINA successfully identifies near-native conformations that are present in the AF3 decoy pool but overlooked by ipTM. Ablation experiments further confirm the critical contributions of atom-level graphs, many-body geometric modules, and the joint loss design. Overall, TINA demonstrates that independent, interface-focused post-hoc scoring remains a valuable complement to AF3, particularly for challenging complexes where local geometric discrimination is critical for accurate model selection.</p>","PeriodicalId":6942,"journal":{"name":"Acta Pharmacologica Sinica","volume":" ","pages":""},"PeriodicalIF":10.4000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Pharmacologica Sinica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41401-026-01937-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Accurate identification of the most native-like conformation remains a critical bottleneck in protein complex structure prediction, particularly when multiple globally plausible candidate models are generated by deep learning methods such as AlphaFold3 (AF3). While AF3 provides internal confidence metrics such as ipTM and pLDDT, these signals often lack sufficient sensitivity to distinguish subtle but structurally meaningful differences in local interface geometry. Here, we present TINA, a geometry-aware post-hoc scoring framework designed for fine-grained ranking and selection among high-quality protein complex candidates. TINA constructs atom-level interface graphs and explicitly models two-body, three-body, and four-body geometric interactions through a many-body tensor modeling strategy, enabling a more comprehensive characterization of local contact patterns, angular arrangements, and torsional constraints. The model is initially trained using a joint ranking and regression objective on a large decoy set generated by ZDOCK, with additional task-specific fine-tuning for protein-peptide complexes, and is evaluated exclusively on AF3-generated candidate pools across four independent benchmarks covering general protein-protein, antibody-antigen, protein-peptide, and antibody-peptide complexes. TINA consistently achieves superior or competitive performance in terms of top-1 success rate, enrichment factor, and top-1 DockQ quality. Notably, its benefit is most pronounced in low-confidence and antibody-related scenarios, where AF3 internal ranking signals are less effective in discriminating among candidate conformations. Representative case studies demonstrate that TINA successfully identifies near-native conformations that are present in the AF3 decoy pool but overlooked by ipTM. Ablation experiments further confirm the critical contributions of atom-level graphs, many-body geometric modules, and the joint loss design. Overall, TINA demonstrates that independent, interface-focused post-hoc scoring remains a valuable complement to AF3, particularly for challenging complexes where local geometric discrimination is critical for accurate model selection.

TINA:蛋白质-蛋白质相互作用的几何感知事后评分框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Pharmacologica Sinica
Acta Pharmacologica Sinica 医学-化学综合
CiteScore
15.10
自引率
2.40%
发文量
4365
审稿时长
2 months
期刊介绍: APS (Acta Pharmacologica Sinica) welcomes submissions from diverse areas of pharmacology and the life sciences. While we encourage contributions across a broad spectrum, topics of particular interest include, but are not limited to: anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal, and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics, and pharmacokinetics. Join us in sharing your research and insights in pharmacology and the life sciences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书